1.38BMarket Cap-6885P/E (TTM)
20.440High19.750Low104.65KVolume20.440Open20.080Pre Close2.09MTurnover0.19%Turnover RatioLossP/E (Static)69.15MShares58.38052wk High2.57P/B1.13BFloat Cap11.25052wk Low--Dividend TTM56.59MShs Float58.380Historical High--Div YieldTTM3.44%Amplitude7.520Historical Low19.993Avg Price1Lot Size
Akero Therapeutics Stock Forum
Any news?
For those that may be affected
Click here to learn more about the investigation: or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
The investigation focuses on Akero's representations...
NASH Basket- $Madrigal Pharmaceuticals(MDGL.US)$$Viking Therapeutics(VKTX.US)$$Akero Therapeutics(AKRO.US)$$89bio(ETNB.US)$
Than we already know how big Obesity market is going to be over next decade with global 1.5 Billion obese pts
Obesity Basket $Viking Therapeutics(VKTX.US)$$Eli Lilly and Co(LLY.US)$$Novo-Nordisk A/S(NVO.US)$
Ph2 readouts in Q1 2024...
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...
No comment yet